Selected research
Industry Growth & Trends
Global Eszopiclone Industry Growth and Trends Forecast to 2032
Market perspective
The global Eszopiclone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Eszopiclone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Eszopiclone is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Eszopiclone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Eszopiclone include Tasly Pharmaceutical, Sun Pharmaceutical, Kanghong Pharmaceutical, Wockhardt, Tapi Teva, Shanghai Pharmaceuticals Holding, Kanghong Pharmaceutical, Glenmark Life Sciences and Dr. Reddy’s Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Eszopiclone market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Eszopiclone market size, estimates, and forecasts are presented in terms of sales volume (tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Eszopiclone market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Eszopiclone.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Eszopiclone market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Eszopiclone Market by Company
Tasly Pharmaceutical
Sun Pharmaceutical
Kanghong Pharmaceutical
Wockhardt
Tapi Teva
Shanghai Pharmaceuticals Holding
Kanghong Pharmaceutical
Glenmark Life Sciences
Dr. Reddy’s Laboratories
Centaur Pharmaceuticals
Admiron Life
Eszopiclone Segment by Type
Purity Above 98%
Purity Below 98%
Eszopiclone Segment by Application
Tablet
Capsule
Other
Eszopiclone Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Eszopiclone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Eszopiclone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Eszopiclone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Eszopiclone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Eszopiclone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity Above 98%
- Purity Below 98%
Applications
- Tablet
- Capsule
- Other
Companies covered
- Tasly Pharmaceutical
- Sun Pharmaceutical
- Kanghong Pharmaceutical
- Wockhardt
- Tapi Teva
- Shanghai Pharmaceuticals Holding
- Kanghong Pharmaceutical
- Glenmark Life Sciences
- Dr. Reddy’s Laboratories
- Centaur Pharmaceuticals
- Admiron Life
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Eszopiclone Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Eszopiclone Sales Estimates and Forecasts (2021-2032)
- 1.3 Eszopiclone Market by Type
- 1.3.1 Purity Above 98%
- 1.3.2 Purity Below 98%
- 1.4 Global Eszopiclone Market Size by Type
- 1.4.1 Global Eszopiclone Market Size Overview by Type (2021-2032)
- 1.4.2 Global Eszopiclone Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Eszopiclone Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Eszopiclone Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Eszopiclone Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Eszopiclone Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Eszopiclone Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Eszopiclone Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Eszopiclone Industry Trends
- 2.2 Eszopiclone Industry Drivers
- 2.3 Eszopiclone Industry Opportunities and Challenges
- 2.4 Eszopiclone Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Eszopiclone Revenue (2021-2026)
- 3.2 Global Top Players by Eszopiclone Sales (2021-2026)
- 3.3 Global Top Players by Eszopiclone Price (2021-2026)
- 3.4 Global Eszopiclone Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Eszopiclone Major Company Production Sites & Headquarters
- 3.6 Global Eszopiclone Company, Product Type & Application
- 3.7 Global Eszopiclone Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Eszopiclone Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Eszopiclone Players Market Share by Revenue in 2025
- 3.8.3 2025 Eszopiclone Tier 1, Tier 2, and Tier 3
4 Eszopiclone Regional Status and Outlook
- 4.1 Global Eszopiclone Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Eszopiclone Historic Market Size by Region
- 4.2.1 Global Eszopiclone Sales in Volume by Region (2021-2026)
- 4.2.2 Global Eszopiclone Sales in Value by Region (2021-2026)
- 4.2.3 Global Eszopiclone Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Eszopiclone Forecasted Market Size by Region
- 4.3.1 Global Eszopiclone Sales in Volume by Region (2027-2032)
- 4.3.2 Global Eszopiclone Sales in Value by Region (2027-2032)
- 4.3.3 Global Eszopiclone Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Eszopiclone by Application
- 5.1 Eszopiclone Market by Application
- 5.1.1 Tablet
- 5.1.2 Capsule
- 5.1.3 Other
- 5.2 Global Eszopiclone Market Size by Application
- 5.2.1 Global Eszopiclone Market Size Overview by Application (2021-2032)
- 5.2.2 Global Eszopiclone Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Eszopiclone Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Eszopiclone Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Eszopiclone Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Eszopiclone Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Eszopiclone Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Eszopiclone Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Tasly Pharmaceutical
- 6.1.1 Tasly Pharmaceutical Company Information
- 6.1.2 Tasly Pharmaceutical Business Overview
- 6.1.3 Tasly Pharmaceutical Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Tasly Pharmaceutical Eszopiclone Product Portfolio
- 6.1.5 Tasly Pharmaceutical Recent Developments
- 6.2 Sun Pharmaceutical
- 6.2.1 Sun Pharmaceutical Company Information
- 6.2.2 Sun Pharmaceutical Business Overview
- 6.2.3 Sun Pharmaceutical Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Sun Pharmaceutical Eszopiclone Product Portfolio
- 6.2.5 Sun Pharmaceutical Recent Developments
- 6.3 Kanghong Pharmaceutical
- 6.3.1 Kanghong Pharmaceutical Company Information
- 6.3.2 Kanghong Pharmaceutical Business Overview
- 6.3.3 Kanghong Pharmaceutical Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Kanghong Pharmaceutical Eszopiclone Product Portfolio
- 6.3.5 Kanghong Pharmaceutical Recent Developments
- 6.4 Wockhardt
- 6.4.1 Wockhardt Company Information
- 6.4.2 Wockhardt Business Overview
- 6.4.3 Wockhardt Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Wockhardt Eszopiclone Product Portfolio
- 6.4.5 Wockhardt Recent Developments
- 6.5 Tapi Teva
- 6.5.1 Tapi Teva Company Information
- 6.5.2 Tapi Teva Business Overview
- 6.5.3 Tapi Teva Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Tapi Teva Eszopiclone Product Portfolio
- 6.5.5 Tapi Teva Recent Developments
- 6.6 Shanghai Pharmaceuticals Holding
- 6.6.1 Shanghai Pharmaceuticals Holding Company Information
- 6.6.2 Shanghai Pharmaceuticals Holding Business Overview
- 6.6.3 Shanghai Pharmaceuticals Holding Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Shanghai Pharmaceuticals Holding Eszopiclone Product Portfolio
- 6.6.5 Shanghai Pharmaceuticals Holding Recent Developments
- 6.7 Kanghong Pharmaceutical
- 6.7.1 Kanghong Pharmaceutical Company Information
- 6.7.2 Kanghong Pharmaceutical Business Overview
- 6.7.3 Kanghong Pharmaceutical Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Kanghong Pharmaceutical Eszopiclone Product Portfolio
- 6.7.5 Kanghong Pharmaceutical Recent Developments
- 6.8 Glenmark Life Sciences
- 6.8.1 Glenmark Life Sciences Company Information
- 6.8.2 Glenmark Life Sciences Business Overview
- 6.8.3 Glenmark Life Sciences Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Glenmark Life Sciences Eszopiclone Product Portfolio
- 6.8.5 Glenmark Life Sciences Recent Developments
- 6.9 Dr. Reddy’s Laboratories
- 6.9.1 Dr. Reddy’s Laboratories Company Information
- 6.9.2 Dr. Reddy’s Laboratories Business Overview
- 6.9.3 Dr. Reddy’s Laboratories Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Dr. Reddy’s Laboratories Eszopiclone Product Portfolio
- 6.9.5 Dr. Reddy’s Laboratories Recent Developments
- 6.10 Centaur Pharmaceuticals
- 6.10.1 Centaur Pharmaceuticals Company Information
- 6.10.2 Centaur Pharmaceuticals Business Overview
- 6.10.3 Centaur Pharmaceuticals Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Centaur Pharmaceuticals Eszopiclone Product Portfolio
- 6.10.5 Centaur Pharmaceuticals Recent Developments
- 6.11 Admiron Life
- 6.11.1 Admiron Life Company Information
- 6.11.2 Admiron Life Business Overview
- 6.11.3 Admiron Life Eszopiclone Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Admiron Life Eszopiclone Product Portfolio
- 6.11.5 Admiron Life Recent Developments
7 North America by Country
- 7.1 North America Eszopiclone Sales by Country
- 7.1.1 North America Eszopiclone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Eszopiclone Sales by Country (2021-2026)
- 7.1.3 North America Eszopiclone Sales Forecast by Country (2027-2032)
- 7.2 North America Eszopiclone Market Size by Country
- 7.2.1 North America Eszopiclone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Eszopiclone Market Size by Country (2021-2026)
- 7.2.3 North America Eszopiclone Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Eszopiclone Sales by Country
- 8.1.1 Europe Eszopiclone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Eszopiclone Sales by Country (2021-2026)
- 8.1.3 Europe Eszopiclone Sales Forecast by Country (2027-2032)
- 8.2 Europe Eszopiclone Market Size by Country
- 8.2.1 Europe Eszopiclone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Eszopiclone Market Size by Country (2021-2026)
- 8.2.3 Europe Eszopiclone Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Eszopiclone Sales by Country
- 9.1.1 Asia-Pacific Eszopiclone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Eszopiclone Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Eszopiclone Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Eszopiclone Market Size by Country
- 9.2.1 Asia-Pacific Eszopiclone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Eszopiclone Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Eszopiclone Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Eszopiclone Sales by Country
- 10.1.1 South America Eszopiclone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Eszopiclone Sales by Country (2021-2026)
- 10.1.3 South America Eszopiclone Sales Forecast by Country (2027-2032)
- 10.2 South America Eszopiclone Market Size by Country
- 10.2.1 South America Eszopiclone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Eszopiclone Market Size by Country (2021-2026)
- 10.2.3 South America Eszopiclone Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Eszopiclone Sales by Country
- 11.1.1 Middle East and Africa Eszopiclone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Eszopiclone Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Eszopiclone Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Eszopiclone Market Size by Country
- 11.2.1 Middle East and Africa Eszopiclone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Eszopiclone Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Eszopiclone Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Eszopiclone Value Chain Analysis
- 12.1.1 Eszopiclone Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Eszopiclone Production Mode & Process
- 12.2 Eszopiclone Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Eszopiclone Distributors
- 12.2.3 Eszopiclone Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst